Related Experiment Video

Updated: Jun 13, 2026

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
04:56

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases

Paolo Puddu1, Giovanni M Puddu, Eleonora Cravero

  • 1Department of Internal Medicine, University of Bologna and S Orsola-Malpighi Hospital, Italy.

The Canadian Journal of Cardiology
|April 14, 2010
PubMed

Insights

Microparticles (MPs), small cell-derived vesicles, are implicated in coagulation and vascular inflammation. Elevated MP levels indicate increased cardiovascular risk and can serve as markers for therapy efficacy.

Area of Science:

  • Cardiovascular Biology
  • Hemostasis and Thrombosis
  • Cellular Biology

Background:

  • Microparticles (MPs) are small vesicles (0.1-2 microm) derived from various blood cells.
  • MPs can transfer cellular material and influence coagulation and vascular function.
  • Elevated MP levels are associated with several cardiovascular diseases.

Purpose of the Study:

  • To review the role of MPs in vascular function and inflammation.
  • To highlight MPs as potential biomarkers for cardiovascular risk.
  • To discuss MPs as surrogate endpoints for therapeutic evaluation.

Main Methods:

  • Literature review of studies on microparticle biology and clinical relevance.
  • Analysis of MP procoagulant and inflammatory properties.
  • Correlation of MP levels with cardiovascular disease states.

Main Results:

  • MPs expose tissue factor and phosphatidylserine, promoting coagulation.
  • MPs modulate endothelial cell function, affecting nitric oxide and prostacyclin production.
  • Increased circulating MPs are observed in acute coronary syndromes, stroke, diabetes, hypertension, and hypertriglyceridemia.

Conclusions:

  • Microparticles are key players in vascular hemostasis and inflammation.
  • Circulating MP levels serve as significant indicators of cardiovascular risk.
  • MPs represent valuable surrogate endpoints for assessing treatment efficacy in cardiovascular therapies.

More Related Videos

Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells09:26

Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells

Published on: February 20, 2015

Routine Screening Method for Microparticles in Platelet Transfusions09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Inflammation01:38

Inflammation

Overview
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...